What Resolution RDC 204, 2017 - Good Manufacturing Practices for Pharmaceutical Inputs: Active Ingredients, Excipients and Primary Packaging requires
This regulation requires pharmaceutical manufacturers to comply with Good Manufacturing Practices (GMP) as outlined in Article…
This is a preview. The full record adds the complete summary, 10 workflow steps, 7 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: Agência Nacional de Vigilância Sanitária (ANVISA) · Version: 1.0.1 · Last updated:
Primary source: https://www.gov.br/anvisa/pt-br/assuntos/medicamentos
SHA-256 integrity: 56988796f943387708e0b09982c46845d831e9f510120adb7444b880ce8c7259
Primary Citations — 5 traced to source
- Resolution RDC 204, 2017, Article 5 - Good Manufacturing Practices
- Resolution RDC 204, 2017, Article 7 - Quality Control
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/brazil-anvisa-resolution-rdc-204-2017.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/brazil-anvisa-resolution-rdc-204-2017.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/brazil-anvisa-resolution-rdc-204-2017
- Back to registry: Browse all 10,102 compliance nodes